Gemzar

In the US, Gemzar (gemcitabine systemic) is a member of the drug class antimetabolites and is used to treat Breast Cancer, Breast Cancer - Metastatic, Non-Small Cell Lung Cancer, Ovarian Cancer and Pancreatic Cancer.

US matches:

• Gemzar

Ingredient matches for Gemzar

Gemcitabine

Gemcitabine is reported as an ingredient of Gemzar in the following countries:

• Bangladesh


• Luxembourg


• Peru


• Russian Federation


• Slovenia


• Tunisia

Gemcitabine hydrochloride (a derivative of Gemcitabine) is reported as an ingredient of Gemzar in the following countries:

• Australia


• Austria


• Bahrain


• Belgium


• Bosnia & Herzegowina


• Brazil


• Bulgaria


• Canada


• Chile


• Colombia


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Egypt


• Estonia


• Finland


• France


• Germany


• Greece


• Hong Kong


• Hungary


• Iceland


• Indonesia


• Iran


• Iraq


• Ireland


• Israel


• Italy


• Japan


• Jordan


• Kenya


• Kuwait


• Latvia


• Lebanon


• Lithuania


• Luxembourg


• Malaysia


• Malta


• Mexico


• Netherlands


• New Zealand


• Nigeria


• Norway


• Oman


• Philippines


• Poland


• Portugal


• Qatar


• Romania


• Russian Federation


• Saudi Arabia


• Serbia


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sri Lanka


• Sweden


• Switzerland


• Syria


• Taiwan


• Tanzania


• Thailand


• Turkey


• Uganda


• United Arab Emirates


• United Kingdom


• United States


• Yemen

International Drug Name Search